Evidence map›Paper›PMID 41639675›Full record

ArticleJournal of nanobiotechnology2026

Cascade catalytic nanozyme platform for combined antibacterial, anti-inflammatory, and pro-healing therapy of infected diabetic wounds.

Siyu Liu, Hongyu Chen, Yan Xu, Leijiao Li, Xincui Shi, Imre Varga, Guihua Cui, Wenliang Li

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Siyu Liu *School of Chemistry and Environmental Engineering, Changchun University of Science and Technology, Changchun, 130022, P. R. China.
Hongyu Chen *Jilin Provincial Key Laboratory on Molecular and Chemical Genetics, The Second Hospital of Jilin University, Changchun, 130041, P. R. China.
Yan XuSchool of Chemistry and Environmental Engineering, Changchun University of Science and Technology, Changchun, 130022, P. R. China.
Leijiao LiSchool of Chemistry and Environmental Engineering, Changchun University of Science and Technology, Changchun, 130022, P. R. China. lileijiao@cust.edu.cn.
Xincui ShiSchool of Chemistry and Environmental Engineering, Changchun University of Science and Technology, Changchun, 130022, P. R. China.
Imre VargaInstitute of Chemistry, Eötvös Loránd University, Pázmány P. s. 1/A, 1117 , Budapest, Hungary.
Guihua CuiSchool of pharmacy, Jilin Medical University, Jilin, 132013, P. R. China.
Wenliang LiSchool of Chemistry and Environmental Engineering, Changchun University of Science and Technology, Changchun, 130022, P. R. China. wenliangl@ciac.ac.cn.

Funding

Projects of Intra-Party Budgetary Basic Construction Funds of Jilin Provincial Development and Reform Commission 2024C019-9the Educational Commission of Jilin Province of China JJKH20240903KJthe International Science and Technology Cooperation Plan of Jilin City 20240601024the Natural Science Foundation Project of Jilin Province Science and Technology Department 20250102095JC
6 · The paper itself

Abstract

The wounds of diabetic patients are prone to bacterial infection due to complex microenvironments. Improving the microenvironment of diabetic wounds and controlling bacterial infection are crucial for wound healing in diabetic patients. We constructed a cascade catalytic antibacterial agent (h-CuSe-PEG/GOx) by using the hollow copper selenide nanocubes (h-CuSe NCs) loaded with glucose oxidase (GOx). The sythesized h-CuSe NCs possess peroxidase-like (POD-like), glutathione peroxidase-like (GPx-like), and oxidase-like (OXD-like) activities. The loaded GOx can reduce the wound pH and generate H2O2 in situ, further enhancing the catalytic reactive oxygen species (ROS) generation. The h-CuSe-PEG/GOx exhibited efficient antimicrobial properties against Gram-negative Escherichia coli (E. coli), Gram-positive Staphylococcus aureus (S. aureus), as well as ampicillin-resistant Escherichia coli (MREC) and methicillin-resistant Staphylococcus aureus (MRSA). The results of in vivo experiments showed that h-CuSe-PEG/GOx reduced the expression of pro-inflammatory cytokines interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) by inhibiting bacterial growth, thereby alleviating the inflammatory response. At the same time, it enhanced the expression of cluster of differentiation 31 (CD31) and vascular endothelial growth factor (VEGF) and promoted angiogenesis. Therefore, the use of cascade catalytic nanozyme strategy can effectively control bacterial infection, improve wound microenvironment and promote wound healing, which is of clinical significance for the treatment of diabetic wounds.

Indexed as

Anti-Bacterial AgentsAnti-Inflammatory AgentsWound HealingAnimalsCatalysisCopperDiabetes ComplicationsEscherichia coliGlucose OxidaseHumansMaleMethicillin-Resistant Staphylococcus aureusMiceReactive Oxygen SpeciesStaphylococcus aureusAnti-Bacterial AgentsAnti-Inflammatory AgentsCopperGlucose OxidaseReactive Oxygen SpeciesAntibacterialCascade catalyticDiabetic woundsh-CuSe-PEG/GOxHealing therapyReactive oxygen species (ROS)

Identifiers

PMID41639675
PMCPMC12879433

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.